Novavax Jumps While J&J Falls on Vaccine News By

© Reuters

By Liz Moyer — GameStop Corp (NYSE:) and AMC Entertainment Holdings Inc (NYSE:) aren’t the only hot stocks on Friday. Novavax Inc (NASDAQ:) jumped 65% after its Covid-19 vaccine candidate showed 89.3% effectiveness in a U.K. trial.

That compares to the 72% efficacy shown in a U.S. trial of Johnson & Johnson (NYSE:)’s vaccine candidate. Shares of J&J fell 4.6%. J&J said its candidate showed less effectiveness in trials outside the U.S.

Still, the prospect of two more vaccines coming to market soon should be good news for markets in general, though they weren’t acting like it on Friday. The was down more than 600 points as of midday. 


Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.